Donate
Email Password
Not a member? Sign Up   Forgot password?
Business and Economics Education Environment Health Care California
Home
About PRI
My PRI
Contact
Search
Policy Research Areas
Events
Publications
Press Room
PRI Blog
Jobs Internships
Scholars
Staff
Book Store
Policy Cast
Upcoming Events
WSJ's Stephen Moore Book Signing Luncheon-Rescheduled for December 17
12.17.2012 12:00:00 PM
Who's the Fairest of Them All?: The Truth About Opportunity, ... 
More

Recent Events
Victor Davis Hanson Orange County Luncheon December 5, 2012
12.5.2012 12:00:00 PM

Post Election: A Roadmap for America's Future

 More

Post Election Analysis with George F. Will & Special Award Presentation to Sal Khan of the Khan Academy
11.9.2012 6:00:00 PM

Pacific Research Institute Annual Gala Dinner

 More

Reading Law: The Interpretation of Legal Texts
10.19.2012 5:00:00 PM
Author Book Signing and Reception with U.S. Supreme Court Justice ... More

Opinion Journal Federation
Town Hall silver partner
Lawsuit abuse victims project
Events Archive
E-mail Print Evidence, Economics, and Politics: Australia’s Experiment in Evidence-Based Medicine
PRI Event

Start : Friday, December 15, 2006 07:30 AM
End : Friday, December 15, 2006 10:30 AM

 

California Healthcare Institute 

Evidence, Economics, and Politics:
Australia’s Experiment in Evidence-Based Medicine

Friday, December 15, 2006
7:30 a.m. - 10:30 a.m
St. Regis Hotel
125 3rd Street (near Mission)
San Francisco, CA 94103

Registration and Continental Breakfast: 7:30 a.m.
Panel Discussion: 8:00 a.m.


Australia’s National Health Systems (NHS) provides universal, tax-financed coverage to all citizens. To control the cost of medicines, NHS created a Pharmaceutical Benefits Advisory Committee (PBAC) to advise whether and, if so, how government should subsidize drugs. A central feature of PBAC is cost-effectiveness research. With U.S. policymakers searching for ways to rein in Medicare and Medicaid drug spending, the Australian experience assumes special relevance.

Join CHI - California Healthcare Institute, Pacific Research Institute, and policy experts from Australia and the U.S. for a discussion of the promise and pitfalls of cost-effectiveness analysis, a subject already of intense interest to the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS).

Moderator:

  • John R. Graham
    Director, Health Care Studies, Pacific Research Institute, and former Director of Health & Pharmaceutical Policy Research at Canada’s Fraser Institute  



Panelists:

  • Kwabena O.M. Adubofour, MD
    Medical Director, Fifth Street Medical Center - South Stockton, CA
    View Powerpoint Presentation


  • Meryl Comer
    Journalist and Caregiver

  • Randolph Frankel
    Vice President, Public Affairs & Government Relations, IMS Health

  • Marjorie Ginsburg
    Executive Director, Sacramento Healthcare Decisions
    View PowerPoint Presentation


  • Ruth Lopert
    Harkness Fellow in Health Care Policy, George Washington University and Principal Advisor, Pharmaceutical Policy Taskforce, Commonwealth Department of Health and Ageing, Canberra, Australia
    View Powerpoint Presentation


  • Peter J. Pitts
    Co-Founder and President, Center for Medicines in the Public Interest, and former FDA Associate Commissioner for External Relations



There is no cost to attend this conference, however space is limited.
Register online by Wednesday, December 13, 2006


 Evidence, Economics, and Politics

 PRI's John R. Graham moderating panel discussion

 Evidence, Economics and Politics2

 PRI Board Member, Mike Carpenter and guest

 Evidence, Economics, and Politics3

 Mike Carpenter, John R. Graham, Meryl Comer, and Governor Pete Wilson




Questions?
Contact Shawn Bonsack (bonsack@chi.org or 858-551-6677).
Cindy Chin (cchin@pacificresearch.org or 415-955-6110).

Sponsors:
California Healthcare Institute
Pacific Research Institute
 


Within Events
Browse by
Recent Publications
Events Archive
Powered by eResources